Moneycontrol PRO
HomeNewsSequent scientific

Sequent Scientific

Jump to
  • Sequent Scienti Standalone September 2025 Net Sales at Rs 34.03 crore, down 18.96% Y-o-Y

  • Trade Spotlight: How should you trade Bajaj Finance, Tata Motors, United Spirits, BHEL, Cholamandalam Investment, Godawari Power, and others on September 23?

    Rangebound trading may continue, and Monday's low could be crucial for further direction. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade Canara Bank, Swiggy, Sequent Scientific, Phoenix Mills, GE Shipping, AGI Infra, and others on September 22?

    Consolidation may be seen for a few more sessions before entering a new leg of the upmove. Below are some short-term trading ideas to consider.

  • Trade Spotlight: How should you trade JSW Steel, Varroc Engg, Apollo Tyres, Ashok Leyland, TVS Motor, Aditya Birla Capital, and others on September 09?

    The frontline indices are likely to rally if they start trading above all key moving averages. Below are some short-term trading ideas to consider.

  • Sequent Scienti Standalone June 2025 Net Sales at Rs 41.07 crore, down 28.78% Y-o-Y

  • Sequent Scienti Standalone March 2025 Net Sales at Rs 42.33 crore, up 15.12% Y-o-Y

  • Sequent Scienti Consolidated December 2024 Net Sales at Rs 390.81 crore, up 18.66% Y-o-Y

  • Sequent Scienti Standalone December 2024 Net Sales at Rs 36.27 crore, down 14.06% Y-o-Y

  • Sequent Scienti Consolidated September 2024 Net Sales at Rs 368.65 crore, up 6.56% Y-o-Y

  • Sequent Scienti Standalone September 2024 Net Sales at Rs 41.99 crore, down 14.51% Y-o-Y

  • Bulk deals: Morgan Stanley, Societe Generale, Citigroup buy 2.8% stake in Sterling and Wilson Renewable Energy

    Promoters - Shapoorji Pallonji and Company sold 5.78 percent stake in Sterling at an average price of Rs 623.28 per share, and Khurshed Yazdi Daruvala offloaded 1.35 percent shares in Sterling and Wilson Renewable Energy at an average price of Rs 630.01 per share.

  • Sequent Scientific shares rise 12% over Rs 8,000-crore merger with Viyash Life Sciences

    The rationale for the merger is to 'build a unique, differentiated, global end-to-end integrated platform with leadership in animal pharmaceuticals, supported by strong operating and R&D backbone', said the companies

  • Sequent Scienti Consolidated June 2024 Net Sales at Rs 390.21 crore, up 17.11% Y-o-Y

  • Sequent Scientific hits 52-week high after pre-qualification approval from WHO for Albendazole API

    Albendazole is used to treat parasitic infections, such as tapeworm, roundworm, and hookworm infestations, which disproportionately affect populations in low- and middle-income countries.

  • Stock Radar: IndusInd Bank, Zomato, HCL Tech, Saraswati Saree Depot, Nucleus Software in focus on Tuesday

    HCL Technologies, MRO-TEK Realty, Bajaj Auto, Motilal Oswal Financial Services, IndusInd Bank, Hi-Tech Pipes, Sequent Scientific, and Prudent Corporate Advisory Services will also be in focus on August 20.

  • Sequent Scienti Standalone June 2024 Net Sales at Rs 57.67 crore, up 42.67% Y-o-Y

  • Sequent Scienti Consolidated March 2024 Net Sales at Rs 361.20 crore, down 1.49% Y-o-Y

  • Sequent Scienti Standalone March 2024 Net Sales at Rs 36.77 crore, down 21.08% Y-o-Y

  • Sequent Scienti Consolidated December 2023 Net Sales at Rs 329.36 crore, down 12.24% Y-o-Y

  • Sequent Scienti Standalone December 2023 Net Sales at Rs 42.21 crore, down 25.95% Y-o-Y

  • Sequent Scienti Consolidated September 2023 Net Sales at Rs 345.97 crore, up 2.48% Y-o-Y

  • Sequent Scienti Standalone September 2023 Net Sales at Rs 49.12 crore, down 9.43% Y-o-Y

  • Sequent Scientific zooms 9% as board approves sale of Thane API facility

    Sequent Scientific is involved in the animal health business working on veterinary active pharmaceutical ingredients and formulations.

  • Sequent Scienti Consolidated June 2023 Net Sales at Rs 333.21 crore, down 2.38% Y-o-Y

  • Sequent Scienti Standalone June 2023 Net Sales at Rs 40.42 crore, down 37.68% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347